Relationship between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis from the HF-ACTION Study

BACKGROUND: Galectin-3 (Gal-3) is a marker of myocardial fibrosis, and elevated levels are associated with adverse outcomes. Mineralocorticoid receptor antagonists (MRA) modulate cardiac fibrosis in HF patients, and have been shown to improve long term outcomes. We examined whether treatment effects...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fiuzat, Mona, Schulte, Phillip J., Felker, G. Michael, Ahmad, Tariq, Neely, Megan, Adams, Kirkwood F., Donahue, Mark P., Kraus, William E., Piña, Ileana L., Whellan, David J., O’Connor, Christopher M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930443/
https://ncbi.nlm.nih.gov/pubmed/24304938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2013.11.011
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge